http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106474468-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32434
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
filingDate 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106474468-B
titleOfInvention Compound adjuvant, vaccine containing compound adjuvant and preparation method of vaccine
abstract The invention relates to a composite adjuvant, a vaccine containing the composite adjuvant and a preparation method of the vaccine, wherein the composite adjuvant comprises a noncompetitive inhibitor of indoleamine-2,3 dioxygenase and an aluminum salt, the noncompetitive inhibitor of indoleamine-2,3 dioxygenase is 4-phenylimidazole, and the content of the 4-phenylimidazole is 0.5-1.5 mg; the aluminum salt is aluminum hydroxide, and the content of the aluminum hydroxide is 300 mu g. The composite adjuvant has the advantages of easily available raw materials, simple preparation process, low cost, stable performance and small toxic and side effects, promotes immune response from positive and negative aspects of body immune regulation, is safe and reliable to use within an immune dose range, can effectively induce antigen-specific humoral immune response, remarkably enhances antigen-specific humoral immune response, and has an effect superior to that of a vaccine without adjuvant, a single adjuvant and an aluminum adjuvant group.
priorityDate 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448226434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6527064
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413876168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176082
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11292
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453694953

Total number of triples: 30.